Kaken Pharmaceutical Co., Ltd. reported consolidated earnings results for the nine months ended December 31, 2018. For the period, the company reported net sales of JPY 72,584 million compared to JPY 76,891 million a year ago. Operating profit was JPY 19,903 million compared to JPY 23,706 million a year ago. Profit was JPY 14,247 million compared to JPY 16,859 million a year ago. Basic earnings per share were JPY 356.84 compared to JPY 416.06 a year ago.

The company provided consolidated earnings guidance for the year ending March 31, 2019. For the period, the company expects net sales to be of JPY 94,800 million, operating profit expects of JPY 22,500 million, profit attributable to owners of parent of JPY 16,400 million and basic earnings per share of JPY 412.91.

The company provided dividend guidance for the year ending March 31, 2019. For the period, the company expects to pay dividend of JPY 75.00 per share compared to JPY 75.00 per share paid a year ago.